Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07586397 · ClinicalTrials.gov registry record · NA
HIPS Feasibility Randomized Controlled Trial
A NA study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07586397: Recruiting NA study, sponsored by Massachusetts General Hospital.
NCT07586397 is a NA study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07586397, a NA study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-determined benchmarks, findings from this trial will be used to assess the feasibility, credibility, and acceptability of both programs (HIPS-1, HIPS-2). In preparation for a future clinical trial powered to test efficacy, we will optimize the protocol for patient recruitment, study protocol, and fidelity materials.
Interventions
- BEHAVIORAL HIPS-1
- BEHAVIORAL HIPS-2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-07-20 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07586397
The ClinicalTrials.gov registry entry for NCT07586397 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which HIPS-1 is the first listed.
NCT07586397 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07586397 about?
NCT07586397 is a clinical study titled "HIPS Feasibility Randomized Controlled Trial". The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain management programs, delivered via live video, for adults with chronic (lasting at least 3 months) and non-arthritic hip-related pain (HRP). Following pre-dete...
What is the current status of trial NCT07586397?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-07-20. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07586397?
The interventions under investigation include: HIPS-1 (BEHAVIORAL), HIPS-2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT07586397?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.